These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9555791)

  • 21. Influence of intravenous n-3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitis.
    Grimminger F; Führer D; Papavassilis C; Schlotzer E; Mayer K; Heuer KU; Kiss L; Walmrath D; Piberhofer S; Lübbecke F
    Eur J Clin Invest; 1993 Nov; 23(11):706-15. PubMed ID: 8307090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma and erythrocyte uptake of omega-3 fatty acids from an intravenous fish oil based lipid emulsion in patients with advanced oesophagogastric cancer.
    Eltweri AM; Thomas AL; Fisk HL; Arshad A; Calder PC; Dennison AR; Bowrey DJ
    Clin Nutr; 2017 Jun; 36(3):768-774. PubMed ID: 27342748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
    Barden AE; Shinde S; Burke V; Puddey IB; Beilin LJ; Irish AB; Watts GF; Mori TA
    Prostaglandins Other Lipid Mediat; 2018 May; 136():1-8. PubMed ID: 29577973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men.
    Zulyniak MA; Perreault M; Gerling C; Spriet LL; Mutch DM
    Metabolism; 2013 Aug; 62(8):1107-13. PubMed ID: 23522836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intravenous lipid emulsions enriched with gamma-linolenic acid on plasma n-6 fatty acids and prostaglandin biosynthesis after burn and endotoxin injury in rats.
    Karlstad MD; DeMichele SJ; Leathem WD; Peterson MB
    Crit Care Med; 1993 Nov; 21(11):1740-9. PubMed ID: 8222692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans.
    Mayer K; Meyer S; Reinholz-Muhly M; Maus U; Merfels M; Lohmeyer J; Grimminger F; Seeger W
    J Immunol; 2003 Nov; 171(9):4837-43. PubMed ID: 14568963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial.
    Wang J; Yu JC; Kang WM; Ma ZQ
    Nutrition; 2012 Jun; 28(6):623-9. PubMed ID: 22113064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher docosahexaenoic acid, lower arachidonic acid and reduced lipid tolerance with high doses of a lipid emulsion containing 15% fish oil: a randomized clinical trial.
    D'Ascenzo R; Savini S; Biagetti C; Bellagamba MP; Marchionni P; Pompilio A; Cogo PE; Carnielli VP
    Clin Nutr; 2014 Dec; 33(6):1002-9. PubMed ID: 24525115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats.
    Mancuso P; Whelan J; DeMichele SJ; Snider CC; Guszcza JA; Claycombe KJ; Smith GT; Gregory TJ; Karlstad MD
    Crit Care Med; 1997 Mar; 25(3):523-32. PubMed ID: 9118672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study on n-3 polyunsaturated fatty acids in the treatment of human experimental gingivitis.
    Campan P; Planchand PO; Duran D
    J Clin Periodontol; 1997 Dec; 24(12):907-13. PubMed ID: 9442428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)--a double-blind, randomised, multicentre study in adults.
    Klek S; Chambrier C; Singer P; Rubin M; Bowling T; Staun M; Joly F; Rasmussen H; Strauss BJ; Wanten G; Smith R; Abraham A; Szczepanek K; Shaffer J
    Clin Nutr; 2013 Apr; 32(2):224-31. PubMed ID: 22796064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
    Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
    Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
    Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. n-3 fatty acids and cardiovascular events after myocardial infarction.
    Kromhout D; Giltay EJ; Geleijnse JM;
    N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study.
    Henneicke-von Zepelin HH; Mrowietz U; Färber L; Bruck-Borchers K; Schober C; Huber J; Lutz G; Kohnen R; Christophers E; Welzel D
    Br J Dermatol; 1993 Dec; 129(6):713-7. PubMed ID: 8286257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis.
    Kurlandsky LE; Bennink MR; Webb PM; Ulrich PJ; Baer LJ
    Pediatr Pulmonol; 1994 Oct; 18(4):211-7. PubMed ID: 7838619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.